AAAAAA
Results:
1-20
|
Results: 20
Authors:
Karapetis, CS
Yip, D
Virik, K
Strickland, A
Ryder, K
Cowling, M
Harper, PG
Citation: Cs. Karapetis et al., Epirubicin, cisplatin, and prolonged or brief infusional 5-fluorouracil inthe treatment of carcinoma of unknown primary site, MED ONCOL, 18(1), 2001, pp. 23-32
Authors:
Underhill, CR
Parnis, FX
Highley, MS
Ahern, J
Harper, PG
Hansen, H
Lund, B
Dombernowsky, P
Hirsch, F
Hansen, M
Carmichael, J
Williams, C
Citation: Cr. Underhill et al., Multicenter phase II study of gemcitabine in previously untreated patientswith advanced epithelial ovarian cancer, ANTI-CANC D, 12(8), 2001, pp. 647-652
Authors:
Strickland, AH
Karapetis, CS
Yip, D
Harper, PG
Citation: Ah. Strickland et al., Adjuvant chemotherapy for gastro-oesophageal cancer with epirubicin, cisplatin and fluorouracil: A single-centre experience, CL ONCOL-UK, 13(1), 2001, pp. 66-66
Authors:
Steer, CB
Marx, GM
Harper, PG
Citation: Cb. Steer et al., Is there quality in clinical benefit?, ANN ONCOL, 12(9), 2001, pp. 1191-1193
Authors:
Halford, S
Yip, D
Karapetis, CS
Strickland, AH
Steger, A
Khawaja, HT
Harper, PG
Citation: S. Halford et al., A phase II study evaluating the tolerability and efficacy of CAELYX (liposomal doxorubicin, Doxil) in the treatment of unresectable pancreatic carcinoma, ANN ONCOL, 12(10), 2001, pp. 1399-1402
Authors:
Karapetis, CS
Strickland, AH
Yip, D
van der Walt, JD
Harper, PG
Citation: Cs. Karapetis et al., PET and PLAP in suspected testicular cancer relapse: Beware sarcoidosis, ANN ONCOL, 12(10), 2001, pp. 1485-1488
Authors:
Harper, PG
Baker, NJ
Reif, CJ
Citation: Pg. Harper et al., Implementing community-oriented primary care projects in an urban family practice residency program, FAM MED, 32(10), 2000, pp. 683-690
Authors:
Torri, V
Harper, PG
Colombo, N
Sandercock, J
Parmar, MKB
Citation: V. Torri et al., Paclitaxel and cisplatin in ovarian cancer, J CL ONCOL, 18(11), 2000, pp. 2349-2349
Authors:
Yip, D
Strickland, AH
Karapetis, CS
Hawkins, CA
Harper, PG
Citation: D. Yip et al., Immunomodulation therapy in colorectal carcinoma (vol 26, pg 169, 2000), CANC TR REV, 26(4), 2000, pp. 313-313
Authors:
Yip, D
Strickland, AH
Karapetis, CS
Hawkins, CA
Harper, PG
Citation: D. Yip et al., Immunomodulation therapy in colorectal carcinoma, CANC TR REV, 26(3), 2000, pp. 169-190
Authors:
Yeh, JSM
Munn, SE
Plunkett, TA
Harper, PG
Hopster, DJ
du Vivier, AW
Citation: Jsm. Yeh et al., Coexistence of acanthosis nigricans and the sign of Leser-Trelat in a patient with gastric adenocarcinoma: A case report and literature review, J AM ACAD D, 42(2), 2000, pp. 357-362
Authors:
Yip, D
Harper, PG
Citation: D. Yip et Pg. Harper, Predictive and prognostic factors in small cell lung cancer: current status, LUNG CANC, 28(3), 2000, pp. 173-185
Authors:
Hain, SF
O'Doherty, MJ
Timothy, AR
Leslie, MD
Harper, PG
Huddart, RA
Citation: Sf. Hain et al., Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse, BR J CANC, 83(7), 2000, pp. 863-869
Authors:
Karapetis, CS
Yip, D
Harper, PG
Citation: Cs. Karapetis et al., The treatment of metastatic colorectal cancer, INT J CL PR, 53(4), 1999, pp. 287-294
Authors:
Stone, M
Highley, MS
Harper, PG
Poole, D
Citation: M. Stone et al., Awareness of BACUP in primary health care: the potential of voluntary services, BR J GEN PR, 49(441), 1999, pp. 315-316
Authors:
Vermorken, JB
Harper, PG
Buyse, M
Citation: Jb. Vermorken et al., The role of anthracyclines in epithelial ovarian cancer, ANN ONCOL, 10, 1999, pp. 43-50
Authors:
Berek, JS
Bertelsen, K
du Bois, A
Brady, MF
Carmichael, J
Eisenhauer, EA
Gore, M
Grenman, S
Hamilton, TC
Hansen, SW
Harper, PG
Horvath, G
Kaye, SB
Luck, HJ
Lund, B
McGuire, WP
Neijt, JP
Ozols, RF
Parmar, MKB
Piccart-Gebhart, MJ
van Rijswijk, R
Rosenberg, P
Rustin, GJS
Sessa, C
Thigpen, JT
Trope, C
Tuxen, MK
Vergote, I
Vermorken, JB
Willemse, PHB
Citation: Js. Berek et al., Advanced epithelial ovarian cancer: 1998 consensus statements, ANN ONCOL, 10, 1999, pp. 87-92
Authors:
Highley, MS
Underhill, CR
Parnis, FX
Karapetis, C
Rankin, E
Dussek, J
Bryant, B
Rowland, C
Hodson, N
Hughes, J
Harper, PG
Citation: Ms. Highley et al., Treatment of invasive thymoma with single-agent ifosfamide, J CL ONCOL, 17(9), 1999, pp. 2737-2744
Authors:
Yip, D
Ahmad, A
Karapetis, CS
Hawkins, CA
Harper, PG
Citation: D. Yip et al., Matrix metalloproteinase inhibitors: Applications in oncology, INV NEW DR, 17(4), 1999, pp. 387-399
Authors:
Yip, D
Harper, PG
Citation: D. Yip et Pg. Harper, Cancer in the elderly: gathering the evidence, MED J AUST, 170(12), 1999, pp. 577-578
Risultati:
1-20
|